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期研究中通过酵母双杂交筛选出 TFF3 结合蛋白即醛酮还原酶 1C1(AKR1C1)。
AKR1C1 是醛酮还原酶家族的一个成员，除催化作用外，还影响细胞敏感性，以
及细胞生长、凋亡与转移。AKR1C1 与胃癌化疗耐药性增加，预后不良相关，耐
药的胃癌细胞中 AKR1C1 表达升高，促进胃癌细胞增殖，拮抗胃癌细胞凋亡。 
本课题主要验证了胃癌细胞中 TFF3 与 AKR1C1 二者的结合及结合模式，
并进一步探讨二者结合对胃癌细胞转移的调控与具体分子机制。首先，应用免疫
组化和定量 PCR 从组织水平与细胞水平两个层面明确了 TFF3 及 AKR1C1 在胃
癌组织中的表达特征，即二者在胃癌中均表达上调；其次构建了外源表达质粒，
应用免疫共沉淀 CO-IP 进一步验证胃癌细胞中 TFF3 与 AKR1C1 的结合，再次，
在野生型以及干扰内源 AKR1C1 表达的胃癌细胞中进行 TFF3 过表达后，分别应
用 CCK8 细胞活性检测技术检测细胞增殖情况、Transwell 小室及 Woundhealing
划痕试验检测细胞迁移侵袭情况、凋亡小体检测实验检测细胞凋亡情况，明确了

















综上，本课题明确了胃癌中 TFF3 与 AKR1C1 表达上调并相互结合，影响了











































Gastric cancer is one of the most common cancers in the world and one of the 
most common causes of cancer-related deaths worldwide. Globally, gastric cancer 
ranks fourth in cancer incidence, Gastric cancer is the second leading cause of cancer 
deaths. The majority of gastric cancer patients have reached advanced stage when 
diagnosed, losing the best time of surgery, or having a high recurrence rate after 
resection. For advanced stage patients, most have shown metastasis. local adjuvant or 
neoadjuvant therapy combined with surgery is usually associated with a poor 
prognosis. The median survival of patients is about 1 year. To find early diagnosis and 
effective targeted therapy is the focus of gastric cancer research in recent years. 
Trefoil factor family 3 (TFF3) is a member of the trefoil factor family protein 
specifically expressed in the gastrointestinal tract. TFF3 is mainly secreted in 
intestinal mucosa and is not detected in gastric mucosa, but is expressed in gastric 
cancer. TFF3 is an oncogene, which is closely related to the development and 
progression of gastric cancer. The growth, apoptosis and migration of gastric cancer 
cells are regulated by NF-κB, EGFR and PI3K-Akt pathways. TFF3 can promote the 
cell dispersion by reducing cell-cell or cell-matrix interactions and further improving 
cell migration. In this study, the TFF3 binding protein, alde-keto reductase 
1C1(AKR1C1), was screened by yeast two-hybrid. AKR1C1 is a member of the 
aldose reductase family, in addition to catalysis, but also affect cell sensitivity, as well 
as cell growth, apoptosis and metastasis. AKR1C1 increased gastric cancer 
chemotherapy resistance, poor prognosis. Increased expression of AKR1C1 in 
chemotherapy resistant gastric cancer cells, promote gastric cancer cell proliferation, 
antagonize gastric cancer cell apoptosis. 
This study focused on the combination of TFF3 and AKR1C1 in gastric cancer 
cells, and further explored the regulation of gastric cancer cell metastasis and specific 
molecular mechanisms. First, the expression characteristics of TFF3 and AKR1C1 in 
gastric carcinoma were identified by immunohistochemistry and quantitative PCR 
from the two levels of tissue level and cell level, that is, both were up-regulated in 
gastric cancer, followed by the construction of exogenous expression plasmid, 















gastric cancer cells. Thirdly, TFF3 overexpression was observed in wild-type and 
gastric cancer cells expressing endogenous AKR1C1, and cell proliferation was 
detected by CCK8 cell activity assay. Transwell chamber and Woundhealing scratch 
test were used to detect the invasion and invasion of cells. Apoptosis was detected by 
apoptotic body test. The effect of AKR1C1 on the proliferation / invasion of gastric 
cancer cells was confirmed by TFF3. Finally, Western blotting was used to detect 
AKT Pathway activation level and expression of EMT-related marker protein in 
epithelial-mesenchymal transition. 
In conclusion, the expression of TFF3 and AKR1C1 in gastric cancer was 
up-regulated and correlated with each other, which affected the activation level of 
AKT pathway and promoted epithelial-mesenchymal transformation of EMT. Thus, 
AKR1C1 played a role in TFF3 promoting the invasion and invasion of gastric cancer 
cells , The two jointly promote the occurrence and development of gastric cancer. 
Therefore, this topic complements TFF3 through its binding protein-mediated 
regulation of the development of gastric cancer in the new mechanism, and suggest 
that AKR1C1 may be used as a new target in the clinical diagnosis and treatment of 
gastric cancer. 
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